quinacrine has been researched along with Obesity in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 3 |
| Zhou, J | 3 |
| Hu, Z | 3 |
| Han, L | 3 |
| Zhao, W | 3 |
| Wu, T | 3 |
| Li, C | 3 |
| Liu, J | 3 |
| Kang, J | 3 |
| Chen, X | 3 |
| Frey, RO | 1 |
| Bühler, EM | 1 |
| Bühler, UK | 1 |
| Stalder, GR | 1 |
2 other studies available for quinacrine and Obesity
| Article | Year |
|---|---|
Quinacrine attenuates diet-induced obesity by inhibiting adipogenesis via activation of AMPK signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; | 2023 |
Quinacrine attenuates diet-induced obesity by inhibiting adipogenesis via activation of AMPK signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; | 2023 |
Quinacrine attenuates diet-induced obesity by inhibiting adipogenesis via activation of AMPK signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; | 2023 |
Quinacrine attenuates diet-induced obesity by inhibiting adipogenesis via activation of AMPK signaling.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; | 2023 |
[45,X/46,SYq dic-Sexchromosome mosaic].
Topics: Adult; Blood Cells; Cells, Cultured; Child; Female; Fibroblasts; Fluorescence; Hair; Humans; Hypogon | 1975 |